bluebirdbio.com rank 184 |
Number of domains linking to bluebirdbio.com 5 | semantic flow 0.35 |
Number of links to bluebirdbio.com 5 | semantic flow 0.35 |
Number of domains linked from bluebirdbio.com 8 | semantic flow 0.55 |
Number of links from bluebirdbio.com 15 | semantic flow 0.55 |
Pages with highest topical PageRank pointing to domain.
url / atext / target url | |
---|---|
https://lifescivc.com/2015/11/cell-and-gene-therapy-an-outside-in-technology-evolution/ bluebird bio in 2010 ↳http://investor.bluebirdbio.com/phoenix.zhtml?c=251820&p=irol-newsArticle&ID=1823960 | lifescivc.com |
On-topic pages from domain with highest topical PageRank.
title / url | |||||||||
---|---|---|---|---|---|---|---|---|---|
bluebird bio Announces Closing of Over-Allotment Option in Public Offering | bluebird bio, Inc. http://investor.bluebirdbio.com/news-releases/news-release-details/bluebird-bio-announces- | 0.21 | 0.76 | 28 | 17 | 0 | 0 | 0 | 0 |
Relevant domains with most links to selected domain.
Relevant domains with most links from selected domain.
Pages from domain with most relevant inbound links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
https://www.bluebirdbio.com/ | 2 | 0.15 | 0.88 | 0.14 | 0.91 | yes | 27 | 12 | 0 | 0 | 2 | 2 | |
https://www.bluebirdbio.com/patients-families/gene-therapy/ | 2 | 0.17 | 0.84 | 0.12 | 0.91 | yes | 20 | 11 | 0 | 0 | 0 | 0 | |
http://investor.bluebirdbio.com/phoenix.zhtml?c=251820&p=irol-newsArticle&ID=1823960 | 1 | 0.16 | 0.87 | 0.08 | -1 | - | -1 | -1 | -1 | -1 | 1 | 1 | |
https://www.bluebirdbio.com/our-focus/ | 1 | 0.16 | 0.93 | 0.05 | 0.86 | yes | 18 | 11 | 0 | 0 | 0 | 0 | |
https://www.bluebirdbio.com/sickle-cell-disease | 1 | 0.16 | 0.86 | 0.05 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
http://investor.bluebirdbio.com/ | 1 | 0.16 | 0.94 | 0.05 | 0.94 | yes | 31 | 21 | 0 | 0 | 0 | 0 | |
https://www.bluebirdbio.com/sitemap | 1 | 0.16 | 0.86 | 0.05 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.bluebirdbio.com/severe-diseases | 1 | 0.16 | 0.82 | 0.05 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.bluebirdbio.com/cancer-immunotherapy | 1 | 0.16 | 0.55 | 0.03 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.bluebirdbio.com/our-focus/cancer-immunotherapy/ | 1 | 0.16 | 0.92 | 0.03 | 0.72 | yes | 24 | 12 | 0 | 0 | 0 | 0 |
Pages from domain with most likely on-topic outgoing links.
url | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
http://investor.bluebirdbio.com/news-releases?field_nir_news_date_value%5Bmin%5D=2017 | 43 | 0.16 | 0.95 | 2.91 | 1 | yes | 71 | 61 | 0 | 0 | 0 | 0 | |
http://investor.bluebirdbio.com/news-releases/news-release-details/bluebird-bio-acquires-m | 16 | 0.17 | 0.99 | 1.11 | 0.97 | yes | 28 | 18 | 0 | 0 | 1 | 1 | |
https://www.bluebirdbio.com/ | 12 | 0.15 | 0.88 | 0.59 | 0.91 | yes | 27 | 12 | 0 | 0 | 2 | 2 | |
https://www.bluebirdbio.com/medical-professionals/ | 6 | 0.17 | 0.88 | 0.33 | 0.84 | yes | 22 | 15 | 6 | 1 | 0 | 0 | |
https://www.bluebirdbio.com/patients-families/sickle-cell-disease/ | 5 | 0.17 | 0.87 | 0.07 | -1 | no | -1 | -1 | -1 | -1 | 0 | 0 | |
https://www.bluebirdbio.com/our-focus/publications/ | 4 | 0.17 | 0.88 | 0.09 | 0.58 | yes | 26 | 13 | 4 | 2 | 0 | 0 | |
https://www.bluebirdbio.com/our-focus/cancer-immunotherapy/ | 3 | 0.16 | 0.92 | 0.11 | 0.72 | yes | 24 | 12 | 0 | 0 | 0 | 0 | |
http://investor.bluebirdbio.com/ | 2 | 0.16 | 0.94 | 0.13 | 0.94 | yes | 31 | 21 | 0 | 0 | 0 | 0 | |
https://www.bluebirdbio.com/our-focus/ | 2 | 0.16 | 0.93 | 0.08 | 0.86 | yes | 18 | 11 | 0 | 0 | 0 | 0 | |
https://www.bluebirdbio.com/patients-families/gene-therapy/ | 1 | 0.17 | 0.84 | 0.05 | 0.91 | yes | 20 | 11 | 0 | 0 | 0 | 0 |
Similar domains to domain, based on inbound linking patterns from other relevant domains. This is also known in SEO as topical co-citation.